AstraZeneca Cash on Hand 2010-2024 | AZN

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AstraZeneca cash on hand for 2023 was $6.078B, a 6.38% decline from 2022.
AstraZeneca cash on hand for 2022 was $6.492B, a 0.17% increase from 2021.
AstraZeneca cash on hand for 2021 was $6.481B, a 20.32% decline from 2020.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AstraZeneca cash on hand for 2023 was $6.078B, a 6.38% decline from 2022.
AstraZeneca cash on hand for 2022 was $6.492B, a 0.17% increase from 2021.
AstraZeneca cash on hand for 2021 was $6.481B, a 20.32% decline from 2020.